Helix BioPharma
Manufacturing · Canada · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1055 W Georgia St Suite 2050, Vancouver,...Website
www.helixbiopharma.comRevenue
$6.5 MillionIndustry
About Helix BioPharma
Helix Biopharma is a clinical-stage oncology company focused on developing innovative therapies for difficult-to-treat cancers. Their product pipeline includes L-DOS47, an antibody-enzyme conjugate aimed at enhancing immune response in solid tumors, LEUMUNA, an oral immune checkpoint modulator for leukemia relapse, and GEMCEDA, an oral prodrug of gemcitabine designed for advanced solid tumors. The company targets patients with hard-to-treat cancers, aiming to provide new hope through effective and patient-friendly treatment options.Explore more
Helix BioPharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Helix BioPharma
Compare insights from companies similar to Helix BioPharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Helix BioPharma Tech Stack
A closer look at the technologies used by Helix BioPharma
See more technologies
Top Manufacturing Companies
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Helix BioPharma
Sign Up For FreeTo access detailed company insights
Helix Biopharma is a clinical-stage oncology company focused on developing innovative therapies for difficult-to-treat cancers. Their product pipeline includes L-DOS47, an antibody-enzyme conjugate aimed at enhancing immune response in solid tumors, LEUMUNA, an oral immune checkpoint modulator for leukemia relapse, and GEMCEDA, an oral prodrug of g... Read More
